Faecal microbiota transplant for recurrent Clostridium difficile infection

Recommendation ID: IPG485/1
Question: NICE encourages further research into faecal microbiota transplant for C. difficile infection, specifically to investigate optimal dosage, mode of administration and choice of donor.
Any explanatory notes (if applicable): Current evidence on the efficacy and safety of faecal microbiota transplant for recurrent Clostridium difficile infection is adequate to support the use of this procedure provided that normal arrangements are in place for clinical governance, consent and audit.

Source guidance details

Comes from guidance: Faecal microbiota transplant for recurrent Clostridium difficile infection
Number: IPG485
Date issued: March 2014

Is this a recommendation for the use of a technology only in the context of research?	No
Is it a recommendation that suggests collection of data or the establishment of a register?	No
Last Reviewed	22/05/2014